Find Clinical Trial

Efficacy and safety of Valdoxan® given orally once a day for 24 weeks in patients with Major Depressive Disorder. Open, national, multicentric clinical trial for the evaluation of the antidepressant efficacy and tolerability of ValdoxanR and its additional clinical benefits for depressed patients.


← Back
Study Phase Phase 4
Therapeutic Area Neurosciences
Active Substance AGOMELATINEAGOMELATINE - S020098S020098
SponsorServier Slovensko, spol. s.r.o.
Active Substance CodeS020098
Protocol CodeIC4-20098-542
EudraCT Code2009-010642-57


Documents and links

Scientific publication READ MORE




Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.



© 2017 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.
More information

Report a side-effect with a drug.